faculty photo

Kelly D Getz, PhD, MPH

Assistant Professor of Epidemiology in Biostatistics and Epidemiology
Department: Biostatistics and Epidemiology

Contact information
423 Guardian Drive
909 Blockley Hall
Philadelphia, PA 19104
Office: 215-746-1969
Education:
BS (Biology)
Millersville University, 1997.
MPH (Epidemiology)
Boston University School of Public Health, 2009.
PhD (Epidemiology)
Boston University School of Public Health, 2014.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Pollard JA, Alonzo TA, Gerbing R, Brown P, Fox E, Choi J, Fisher B, Hirsch B, Kahwash S, Getz K, Levine J, Brodersen LE, Loken MR, Raimondi S, Tarlock K, Wood A, Sung L, Kolb EA, Gamis A, Meshinchi S, Aplenc R.: Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031. J Clin Oncol Mar 2022.

McNerney KO, Oranges K, Seif AE, Oshrine B, Ky B, Lin KY, Getz KD, Aplenc R.: Acute Left Ventricular Dysfunction Following Gemtuzumab Ozogamicin in Two Pediatric AML Patients. J Pediatr Hematol Oncol 44: e507-e511, Mar 2022.

Lau-Min KS, Li Y, Eads JR, Mamtani R, Getz KD.: Association between timely targeted treatment and outcomes in patients with metastatic HER2-overexpressing gastroesophageal adenocarcinoma. Cancer Page: doi: 10.1002/cncr.34117. Online ahead of print. Feb 2022.

Yi JS, Chambers TM, Getz KD, Miller TP, Burrows E, Daves MH, Lupo PJ, Scheurer ME, Aplenc R, Rabin KR, Gramatges MM.: A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment. Haematologica Page: Online ahead of print. Jan 2022.

Getz KD, Alonzo TA, Sung L, Meshinchi S, Gerbing RB, Raimondi S, Hirsch B, Loken M, Brodersen LE, Kahwash S, Choi J, Kolb EA, Gamis A, Aplenc R.: Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group. Pediatr Blood Cancer 69(1), Jan 2022.

Kotch C, Avery R, Getz KD, Bouffet E, de Blank P, Listernick R, Gutmann DH, Bornhorst M, Campen C, Liu GT, Aplenc R, Li Y, Fisher MJ.: Risk Factors for Treatment Refractory and Relapsed Optic Pathway Glioma in Children with Neurofibromatosis Type 1. Neuro Oncol Page: doi: 10.1093/neuonc/noac013. Online ahead of print. Jan 2022.

Liberman RF, Heinke D, Petersen JM, Parker SE, Nestoridi E, Van Zutphen AR, Nembhard WN, Ramirez GM, Ethen MK, Tran T, Kirby RS, Getz KD, Nance AE, Yazdy MM; National Birth Defects Prevention Network.: Interpregnancy interval and prevalence of selected birth defects: A multistate study. Birth Defects Res 114: 69-79, Jan 2022.

O'Connor MJ, Zhang X, Griffis H, Fisher BT, Getz KD, Li Y, Rossano JW, Lin KY, Burstein DS, Huang YS, Aplenc R.: Center Variation in Indication and Short-Term Outcomes after Pediatric Heart Transplantation: Analysis of a Merged United Network for Organ Sharing - Pediatric Health Information System Cohort. Pediatr Cardiol 2022.

Narayan HK, Getz KD, Leger KJ.: Minimizing cardiac toxicity in children with acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2021(1): 368-375, Dec 2021.

Elgarten CW, Wood AC, Li Y, Alonzo TA, Brodersen LE, Gerbing RB, Getz KD, Huang YV, Loken M, Meshinchi S, Pollard JA, Sung L, Woods WG, Kolb EA, Gamis AS, Aplenc R.: Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group. Pediatr Blood Cancer 68(12): e29281, Dec 2021.

back to top
Last updated: 03/31/2022
The Trustees of the University of Pennsylvania